Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Alison Woollard© Paul Wilkinson

Professor Alison Woollard, Department of Biochemistry and Fellow of Hertford College, has been appointed as the University of Oxford’s next Academic Champion for Public Engagement with Research.

Professor Woollard will provide academic leadership for the implementation of the University’s Public Engagement with Research strategic plan that was approved by the University’s Research Committee in May 2016. The vision is to embed high-quality and innovative public engagement as an integral part of research culture and practice at Oxford, enhancing our position as a world-leading research institution.

On her appointment, Professor Alison Woollard said: “It is a fantastic time to become Academic Champion. The University is clearly committed to raising the profile of Public Engagement with Research through its Strategic Plan and there could not be a more important time for this”.

Professor Chris Kennard, Head of Division said: “I’m delighted that Alison has been appointed as the University’s Academic Champion for Public Engagement and I look forward to working with her to continue to develop the fantastic ways in which MSD researchers already engage the public with their research.”

Professor Woollard will work alongside Professor Ian Walmsley, who as Pro-Vice-Chancellor for Research and Innovation is responsible for public engagement, and with a network of academic ambassadors from across the University. 

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.